Department of Chemistry, Indian Institute of Technology, Guwahati, Guwahati, Assam 781039, India.
Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, Guwahati, Assam 781039, India.
ACS Infect Dis. 2024 Feb 9;10(2):562-581. doi: 10.1021/acsinfecdis.3c00491. Epub 2024 Jan 31.
Antimicrobial peptides (AMPs) have been an alternate promising class of therapeutics in combating global antibiotic resistance threat. However, the short half-life of AMPs, owing to protease degradability, is one of the major bottlenecks in its commercial success. In this study, we have developed all-D-amino acid containing small cationic peptides P4C and P5C, which are completely protease-resistant, noncytotoxic, nonhemolytic, and potent against the ESKAPE pathogens in comparison to their L analogues. MD simulations suggested marginal improvement in the peptide-binding affinity to the membrane-mimetic SDS micelle (∼ 1 kcal/mol) in response to L → D conversion, corroborating the marginal improvement in the antimicrobial activity. However, L → D chirality conversion severely compromised the peptide:protease (trypsin) binding affinity (≥10 kcal/mol). The relative distance between the scissile peptide carbonyl and the catalytic triad of the protease (H57, D102, and S195) was found to be significantly altered in the D-peptide:protease complex (inactive conformation) relative to the active L-peptide:protease complex. Thus, the poor binding affinity between D-peptides and the protease, resulting in the inactive complex formation, explained their experimentally observed proteolytic stability. This mechanistic insight might be extended to the proteolytic stability of the D-peptides in general and stimulate the rational design of protease-resistant AMPs.
抗菌肽(AMPs)是一种替代的有前途的治疗方法,可用于对抗全球抗生素耐药性的威胁。然而,由于蛋白酶可降解性,AMPs 的半衰期短,这是其商业成功的主要瓶颈之一。在这项研究中,我们开发了全 D-氨基酸的阳离子肽 P4C 和 P5C,与它们的 L 类似物相比,这些肽完全抗蛋白酶降解、无细胞毒性、无溶血作用,对 ESKAPE 病原体具有很强的作用。MD 模拟表明,L→D 转换对肽与模拟细胞膜的 SDS 胶束的结合亲和力略有提高(约 1 kcal/mol),这与抗菌活性的略有提高相符。然而,L→D 手性转换严重降低了肽与蛋白酶(胰蛋白酶)的结合亲和力(≥10 kcal/mol)。与活性 L-肽:蛋白酶复合物相比,在 D-肽:蛋白酶复合物(无活性构象)中,可裂解肽羰基和蛋白酶的催化三联体(H57、D102 和 S195)之间的相对距离发生了显著改变。因此,D-肽与蛋白酶之间的结合亲和力差,导致形成无活性复合物,解释了它们在实验中观察到的抗蛋白酶稳定性。这种机制上的见解可以扩展到一般的 D-肽的蛋白酶稳定性,并刺激具有抗蛋白酶稳定性的 AMP 的合理设计。